How big is the UAE In-Vitro Diagnostics Market?

The UAE In-Vitro Diagnostics Market size is expected to reach USD 423.56 million in 2024 and grow at a CAGR of 5.20% to reach USD 547.86 million by 2029. Read More

What is the current UAE In-Vitro Diagnostics Market size?

In 2024, the UAE In-Vitro Diagnostics Market size is expected to reach USD 423.56 million. Read More

Who are the key players in UAE In-Vitro Diagnostics Market?

bioMérieux, Abbott Laboratories, F Hoffmann-La Roche Ltd, Siemens Healthineers AG and QIAGEN are the major companies operating in the UAE In-Vitro Diagnostics Market. Read More

What years does this UAE In-Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the UAE In-Vitro Diagnostics Market size was estimated at USD 401.53 million. The report covers the UAE In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the UAE In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

UAE In-Vitro Diagnostics Market Analysis | Industry Trends, Size & Forecast Report

UAE In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers UAE Genetic Diagnostics Solution Companies and It is Segmented by Test Type (Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, and Other Test Types), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The Report Offers the Value (in USD) for the Above Segments.

UAE In-Vitro Diagnostics Industry Overview

The UAE in-vitro diagnostics market is moderately competitive due to the presence of some global players in the country along with some local market players. The major market players in the UAE in-vitro diagnostics market are biomérieux, QIAGEN, Abbott Laboratories, Hoffmann-La Roche Ltd, and Siemens Healthineers AG, among others.